4.5 Article

Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction

Journal

JACC-HEART FAILURE
Volume 6, Issue 8, Pages 665-675

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2018.03.003

Keywords

diagnosis; exercise; heart failure; hemodynamics; HFpEF

Funding

  1. National Institutes of Health (NIH) [T32 HL007111]
  2. NIH [RO1 HL128526, R01 HL 126638, U01 HL125205, U10 HL110262]

Ask authors/readers for more resources

OBJECTIVES This study sought to define the invasive hemodynamic correlates of peak oxygen consumption (Vo(2)) in both supine and upright exercise in heart failure with preserved ejection fraction (HFpEF) and evaluate its diagnostic role as a method to discriminate HFpEF from noncardiac etiologies of dyspnea (NCD). BACKGROUND Peak Vo(2) is depressed in patients with HFpEF. The hemodynamic correlates of reduced peak Vo(2) and its role in the clinical evaluation of HFpEF are unclear. METHODS Consecutive patients with dyspnea and normal EF (N = 206) undergoing both noninvasive upright and invasive supine cardiopulmonary exercise testing were examined. Patients with invasively verified HFpEF were compared with those with NCD. RESULTS Compared with NCD (n = 72), HFpEF patients (n = 134) displayed lower peak Vo(2) during upright and supine exercise. Left heart filling pressures during exercise were inversely correlated with peak Vo(2) in HFpEF, even after accounting for known determinants of O-2 transport according to the Fick principle. Very low upright peak Vo(2) (< 14 ml/kg/min) discriminated HFpEF from NCD with excellent specificity (91%) but poor sensitivity (50%). Preserved peak Vo(2) (> 20 ml/kg/min) excluded HFpEF with high sensitivity (90%) but had poor specificity (49%). Intermediate peak Vo(2) cutoff points were associated with substantial overlap between cases and NCD. CONCLUSIONS Elevated cardiac filling pressure during exercise is independently correlated with reduced exercise capacity in HFpEF, irrespective of body position, emphasizing its importance as a novel therapeutic target. Noninvasive cardiopulmonary testing discriminates HFpEF and NCD at high and low values, but additional testing is required for patients with intermediate peak Vo(2). (C) 2018 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available